Bloomberg News

Fresenius Se Results Include Effects of Mark-To-Mark Accounting

November 02, 2011

Nov. 2 (Bloomberg) -- Fresenius SE said its nine-month results include the effects of mark-to-market accounting of the Mandatory Exchangeable Bonds and the Contingent Value Rights related to its acquisition of APP Pharmaceuticals. This will only have an effect on 2011 results, the Bad Homburg, Germany- based health-care company said in an earnings report today.

To contact the editor responsible for this story: Angela Cullen at acullen8@bloomberg.net


We Almost Lost the Nasdaq
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus